Articles Archives - Page 276 of 714

WednesdayApr 06, 2022 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

InMed Pharmaceuticals is a Canadian clinical-stage drug development company focused on the development of rare cannabinoids and their synthetic counterpoints for B2B sales and pharmaceutical potential InMed expects to have rare cannabinoids CBDV and THCV available for B2B sale to the health and wellness market in the coming months, following on the heels of its CBC and CBT products The company recently reported its first revenues from CBC sales in the wake of its acquisition of rare cannabinoids manufacturer BayMedica late last year The company is also working to develop synthetic CBN cannabinoids as potential medical treatments for select conditions,…

TuesdayApr 05, 2022 9:15 am

InnerScope Hearing Technologies Inc. (INND) Seeks to Position for the Launch of the OTC Hearing Aid Law; Inks Agreement with RiteAid.Com

InnerScope Hearing Technologies recently announced that subsidiary HearingAssist’s products would be carried by RiteAid.com The distribution agreement with one of the nation’s leading drug store chains comes as InnerScope seeks to position itself to benefit from the upcoming OTC Hearing Aid Law The Hearing Aid Law will create a new category of hearing aids, available from any retailer without need of doctor appointments or fittings. The law will also see the average cost of these hearing aids decline significantly relative to their current cost – allowing for greater access from the over 40 million Americans unable to afford the product…

TuesdayApr 05, 2022 9:15 am

Blockchain Africa Conference 2022 Opens New Avenues For E-commerce and Business Opportunities

At the juncture of a socio-economic revolution, Africa is open to new opportunities and possibilities forthcoming in the global blockchain ecosystem. Keeping in mind the scope and interest in blockchain and cryptocurrency in the region, Bitcoin Events organized the 2nd virtual and 8th annual edition of the Blockchain Africa Conference on March 17-18th, 2022. The Blockchain Conference witnessed 1964 attendees from 113 countries, on a forum shared by 57 speakers and dignitaries who expressed their views on the business scope of blockchain in Africa. Participants leveraged the virtual conference floor to connect with peers and attended the knowledge-packed 57 sessions…

TuesdayApr 05, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine’s Psychedelic Effect

Cybin-sponsored study will use Kernel Flow, Kernel’s quantitative neuroimaging. Company hopes to learn more about impact ketamine has on brain activity, overall mental well-being. Study results may lead to future studies supporting CYBN’s mission to develop psychedelics into therapeutics. Cybin’s (NEO: CYBN) (NYSE American: CYBN) efforts to transform the mental-health treatment landscape have reached a key milestone: the company is actively recruiting participants for its upcoming feasibility study using Kernel Flow, Kernel’s quantitative neuroimaging technology (https://ibn.fm/9aSxc). “The feasibility study using Kernel Flow offers an opportunity for researchers and our study participants to quantifiably gather information on a psychedelic experience,” said Cybin…

TuesdayApr 05, 2022 9:00 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Leveraging Growth Across Multiple Markets Including Mental Health, Healthcare IT

Mydecine was founded in 2020 as a response to the lack of innovation addressing mental health treatment and the therapeutic possibilities represented by psychedelic compounds and other novel molecules The world is experiencing a shortage of mental health resources, while faced with an increase in mental health issues on the heels of the pandemic Mydecine is leveraging the psychedelic drugs market, the PTSD market, and healthcare IT markets – with potential growth across all avenues In the first year of the COVID-19 pandemic, the prevalence of anxiety and depression worldwide increased by 25%, according to a World Health Organization (“WHO”)…

TuesdayApr 05, 2022 9:00 am

Correlate Infrastructure Partners Inc. (CIPI) Building Climate Change Solutions Through Utilities Analysis for Commercial Facilities

Correlate Infrastructure Partners is a provider of data analysis and scalable services to help commercial and industrial real estate owners meet carbon reduction goals while also improving their net operating income Carbon reduction is a significant part of the multi-national response to climate change concerns, and Correlate Infrastructure Partners is taking a site-specific approach to furthering goals established worldwide in 2015 The company has been known as Triccar, but its stockholders approved changing the company name and ticker symbol in February, with final approval from the SEC expected within the coming days The company’s efforts to redefine itself reflect its…

MondayApr 04, 2022 9:30 am

American Cannabis Partners Helps Michigan Achieve Record Cannabis Sales

Michigan continues to break sales records in the cannabis sector ACP currently operates in Michigan and California and is exploring strategies for expanding operations to two more states The company is focused on three business segments: real estate, acquisition and development of proprietary assets, and ongoing cultivation operations Cannabis sales numbers for December 2021 are in, and Michigan has broken another record (https://ibn.fm/pySD7). This is the kind of news that cannabis operators in the state, including American Cannabis Partners (“ACP”), love to hear. “Michigan closed out 2021 with another record-breaking month of adult-use marijuana sales in December, state officials say,”…

MondayApr 04, 2022 9:15 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) CEO to Present at Three Upcoming Investor Conferences Spotlighting the Company’s Strategic Outlook for the Remainder of 2022

Delic Holdings Co-founder and CEO, Matt Stang, will take part in three upcoming conferences – the Scottdale Capital Event, the Planet MicroCap Showcase, and the H.C. Wainwright Annual Global Life Sciences Conference In presentations and one-on-one meetings, Stang will discuss Delic’s new revenue lines and strategic outlook for the remainder of the year During a recent interview on The Jesse Tee Show, Stang noted the company intends to scale its ketamine clinics as well as build infrastructure to accommodate expanded psychedelic healing The company hopes to utilize its expanded infrastructure to help destigmatize mental health conditions Delic Holdings (CSE: DELC)…

MondayApr 04, 2022 9:15 am

Lightning Network Sees Increase in Popularity; LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Now Has Nine Active Nodes on the Network

The Lightning Network speeds up crypto transactions from around 7 per second (Bitcoin) to 1 million per second (Lightning Network protocol) The Lightning Network was in the news due to it being used by Canadian Prime Minister candidate Pierre Poilievre and the possible use for verification of Twitter users LQwD leverages the Network and provides a proprietary platform as a service (“PaaS”) offering that speeds up transaction times, is cost-effective and easy to use from anywhere in the world Despite recent ups and downs, the cryptocurrency market maintains a strong upward trend, being expected to reach U.S. $2.2 billion by…

MondayApr 04, 2022 9:15 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO John Climaco Shares Company Highlights, Goals at 2022 Virtual Growth Conference Presented by Maxim Group LLC

The three-day event showcased CNS through corporate presentation, fireside chat, and live question and answer sessions CNS has been granted both Orphan Drug Designation and Fast Track status from the FDA for Berubicin in 2020 and 2021, respectively CNS initiated a potentially pivotal global trial of Berubicin for recurrent Glioblastoma Multiforme (“GBM”) with the dosing of the first patients in the trial during 3Q 2021 At the end of 2021, CNS gained approval from swissethics to initiate trial sites in Switzerland for the global trial of Berubicin Virtual event participation can be found on the CNS website under “Events” CNS…

Site Search

Company Search

Category: Articles

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

InnerScope Hearing Technologies Inc. (INND) Seeks to Position for the Launch of the OTC Hearing Aid Law; Inks Agreement with RiteAid.Com

Blockchain Africa Conference 2022 Opens New Avenues For E-commerce and Business Opportunities

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine’s Psychedelic Effect

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Leveraging Growth Across Multiple Markets Including Mental Health, Healthcare IT

Correlate Infrastructure Partners Inc. (CIPI) Building Climate Change Solutions Through Utilities Analysis for Commercial Facilities

American Cannabis Partners Helps Michigan Achieve Record Cannabis Sales

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) CEO to Present at Three Upcoming Investor Conferences Spotlighting the Company’s Strategic Outlook for the Remainder of 2022

Lightning Network Sees Increase in Popularity; LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Now Has Nine Active Nodes on the Network

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO John Climaco Shares Company Highlights, Goals at 2022 Virtual Growth Conference Presented by Maxim Group LLC

Market Basics

Newsletter Publishers

Public Companies